In a recent column, we discussed pacemakers. In this one, we’ll continue on the general topic of heart regulation with information about implantable cardioverter-defibrillators. An implantable ...
Rochester, NY - MI patients with disease severity ranging from New York Heart Association (NYHA) class 1 to 3 benefited from an implantable cardioverter-defibrillator (ICD), according to a secondary ...
Implantable cardioverter-defibrillator (ICD) use is associated with reduced short- and long-term mortality in patients with heart failure, according to late breaking research presented in a Hot Line ...
Hosted on MSN
Implantable cardioverter defibrillators did not improve mortality in selected heart-attack patients
Prophylactic implantable cardioverter defibrillator therapy did not reduce mortality in patients with a prior myocardial infarction, persistent moderate left ventricular systolic dysfunction and ...
Heart failure patients at risk of arrhythmias should not have to wait until after stent insertion before they are fitted with an implantable cardioverter defibrillator device (ICD), according to ...
Clinical trial data, including those from MADIT-CRT, support the use of cardiac resynchronization therapy in patients with asymptomatic and mildly symptomatic heart failure and ventricular ...
heart ecg For patients with symptomatic systolic heart failure not caused by coronary artery disease, an implantable cardioverter-defibrillator (ICD) does not reduce the risk of all-cause mortality, ...
FOOTBALLER Christian Eriksen will be fitted with an implantable cardioverter defibrillator following his cardiac arrest. The device can be life-saving, but what is it ...
UnityPoint Health–St. Luke’s Hospital has become the first hospital in Cedar Rapids to offer a newly approved implantable device designed to protect patients at risk of sudden cardiac arrest. Dr.
More and more heart failure patients are needing a higher shock than the standard delivered by implantable cardioverter-defibrillators to correct their heart rhythm. This week, Biotronik launched the ...
Madrid, Spain – 30 August 2025: Prophylactic implantable cardioverter defibrillator therapy did not reduce mortality in patients with a prior myocardial infarction, persistent moderate left ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results